Voyager Therapeutics (VYGR) PT Lowered to $8 at Wedbush
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Voyager Therapeutics (VYGR) Tops Q1 EPS by 24c, provides guidance
May 13, 2024 4:23 PM EDTVoyager Therapeutics (NASDAQ: VYGR) reported Q1 EPS of ($0.20), $0.24 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $19.5 million versus the consensus estimate of $9.42 million.
Financial Guidance
Voyager is committed to maintaining a strong balance sheet that... More
